Alexander Nowak
Stock Analyst at Lucid Capital
(3.35)
# 2,376
Out of 4,520 analysts
335
Total ratings
41.6%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOCL EDAP TMS | Initiated Coverage: Buy | $10 | $5.44 | +83.99% | 1 | Jun 22, 2026 | |
| HUT Hut 8 | Maintained: Hold | $12 | $91.45 | n/a | 2 | Apr 1, 2024 | |
| CELC Celcuity | Rated: Buy | n/a | $88.38 | n/a | 16 | Mar 28, 2024 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $8 | $7.30 | n/a | 19 | Mar 20, 2024 | |
| INFU InfuSystem Holdings | Rated: Buy | n/a | $8.92 | n/a | 11 | Mar 15, 2024 | |
| KRMD KORU Medical Systems | Rated: Buy | n/a | $4.11 | n/a | 22 | Mar 14, 2024 | |
| PHAT Phathom Pharmaceuticals | Rated: Buy | n/a | $10.94 | n/a | 2 | Mar 8, 2024 | |
| STXS Stereotaxis | Rated: Buy | n/a | $1.55 | n/a | 11 | Mar 5, 2024 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | n/a | $17.08 | n/a | 21 | Mar 5, 2024 | |
| CDNA CareDx | Maintained: Hold | n/a | $39.73 | n/a | 28 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $271.39 | n/a | 27 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $155.87 | n/a | 15 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $1.40 | n/a | 4 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.38 | n/a | 27 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.61 | n/a | 17 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.34 | n/a | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $72.12 | n/a | 17 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.91 | n/a | 18 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.64 | n/a | 1 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.02 | n/a | 8 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $46.70 | n/a | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.30 | n/a | 1 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $15.32 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $303.39 | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $495.76 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.82 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $264.33 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.49 | n/a | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $147.25 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $4 | $12.06 | n/a | 9 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.79 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $19.00 | n/a | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 | $2.24 | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.69 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $6.81 | n/a | 9 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $40 | $5.11 | n/a | 10 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $63.92 | n/a | 1 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $39.52 | n/a | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0111 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $33.71 | n/a | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $5.60 | n/a | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.4195 | n/a | 3 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $36 | $0.000001 | n/a | 8 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $211 | $567.44 | n/a | 1 | Feb 1, 2018 |
EDAP TMS
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $5.44
Upside: +83.99%
Hut 8
Apr 1, 2024
Maintained: Hold
Price Target: $12
Current: $91.45
Upside: n/a
Celcuity
Mar 28, 2024
Rated: Buy
Price Target: n/a
Current: $88.38
Upside: n/a
DiaMedica Therapeutics
Mar 20, 2024
Reiterated: Buy
Price Target: $8
Current: $7.30
Upside: n/a
InfuSystem Holdings
Mar 15, 2024
Rated: Buy
Price Target: n/a
Current: $8.92
Upside: n/a
KORU Medical Systems
Mar 14, 2024
Rated: Buy
Price Target: n/a
Current: $4.11
Upside: n/a
Phathom Pharmaceuticals
Mar 8, 2024
Rated: Buy
Price Target: n/a
Current: $10.94
Upside: n/a
Stereotaxis
Mar 5, 2024
Rated: Buy
Price Target: n/a
Current: $1.55
Upside: n/a
Tandem Diabetes Care
Mar 5, 2024
Maintained: Buy
Price Target: n/a
Current: $17.08
Upside: n/a
CareDx
Feb 29, 2024
Maintained: Hold
Price Target: n/a
Current: $39.73
Upside: n/a
Feb 29, 2024
Rated: Buy
Price Target: n/a
Current: $271.39
Upside: n/a
Feb 23, 2024
Rated: Buy
Price Target: n/a
Current: $155.87
Upside: n/a
Feb 22, 2024
Maintained: Buy
Price Target: $20
Current: $1.40
Upside: n/a
Feb 21, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.38
Upside: n/a
Feb 21, 2024
Rated: Buy
Price Target: n/a
Current: $14.61
Upside: n/a
Feb 15, 2024
Maintained: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Feb 2, 2024
Rated: Buy
Price Target: $80
Current: $72.12
Upside: n/a
Jan 31, 2024
Rated: Buy
Price Target: n/a
Current: $4.91
Upside: n/a
Jan 29, 2024
Rated: Buy
Price Target: n/a
Current: $6.64
Upside: n/a
Jan 24, 2024
Rated: Buy
Price Target: n/a
Current: $3.02
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: n/a
Current: $46.70
Upside: n/a
Jan 2, 2024
Maintained: Buy
Price Target: n/a
Current: $4.30
Upside: n/a
Nov 2, 2023
Maintained: Buy
Price Target: $40
Current: $15.32
Upside: n/a
Oct 11, 2023
Reiterated: Buy
Price Target: n/a
Current: $303.39
Upside: n/a
Oct 9, 2023
Rated: Buy
Price Target: n/a
Current: $495.76
Upside: n/a
Oct 9, 2023
Maintained: Buy
Price Target: n/a
Current: $4.82
Upside: n/a
Oct 9, 2023
Maintained: Buy
Price Target: n/a
Current: $264.33
Upside: n/a
Oct 3, 2023
Maintained: Buy
Price Target: n/a
Current: $1.49
Upside: n/a
Oct 2, 2023
Rated: Buy
Price Target: n/a
Current: $147.25
Upside: n/a
Jul 24, 2023
Maintained: Hold
Price Target: $2 → $4
Current: $12.06
Upside: n/a
Jul 18, 2023
Maintained: Buy
Price Target: n/a
Current: $8.79
Upside: n/a
Jul 14, 2023
Rated: Buy
Price Target: n/a
Current: $19.00
Upside: n/a
Jul 13, 2023
Rated: Buy
Price Target: $60
Current: $2.24
Upside: n/a
May 26, 2023
Rated: Buy
Price Target: n/a
Current: $2.69
Upside: n/a
May 12, 2023
Rated: Buy
Price Target: $8
Current: $6.81
Upside: n/a
May 9, 2023
Rated: Sell
Price Target: $40
Current: $5.11
Upside: n/a
May 2, 2023
Rated: Buy
Price Target: n/a
Current: $63.92
Upside: n/a
Apr 19, 2023
Reiterated: Buy
Price Target: $28
Current: $39.52
Upside: n/a
Feb 22, 2023
Maintained: Buy
Price Target: n/a
Current: $0.0111
Upside: n/a
Feb 14, 2023
Rated: Buy
Price Target: $58
Current: $33.71
Upside: n/a
Feb 9, 2023
Rated: Buy
Price Target: $3
Current: $5.60
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $10 → $5
Current: $0.4195
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $8 → $36
Current: $0.000001
Upside: n/a
Feb 1, 2018
Maintained: Buy
Price Target: $211
Current: $567.44
Upside: n/a